| Name | Priliximab |
|---|
| Description | Priliximab (CEN 000029) is an anti-CD4 humanized monoclonal antibody. Priliximab binds to CD4 on the surface of T cells, resulting in a significant and sustained reduction in circulating CD4+ T cells. Priliximab can be used in research of rheumatoid arthritis (RA)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |